Get the Stockscreener App
94.45
2.41%
2.22
After Hours:
94.74
0.29
+0.31%
Inspire Medical Systems Inc stock is traded at $94.45, with a volume of 714.98K.
It is up +2.41% in the last 24 hours and down -2.16% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$92.23
Open:
$91.05
24h Volume:
714.98K
Relative Volume:
0.48
Market Cap:
$2.74B
Revenue:
$861.31M
Net Income/Loss:
$53.12M
P/E Ratio:
54.72
EPS:
1.7262
Net Cash Flow:
$85.01M
1W Performance:
+2.15%
1M Performance:
-2.16%
6M Performance:
-25.53%
1Y Performance:
-46.84%
1-Day Range:
$89.88
$95.84
1-Week Range:
$89.88
$97.72
52-Week Range:
$70.77
$203.12
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
94.45 | 2.68B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
121.14 | 211.73B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.61 | 139.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
91.20 | 130.61B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
98.60 | 124.05B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.46 | 48.95B | 5.88B | 1.34B | 799.60M | 2.3489 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Update Report: Can Inspire Medical Systems Inc sustain earnings growthJuly 2025 Highlights & AI Powered Market Entry Strategies - baoquankhu1.vn
Inspire Medical Systems, Inc. (INSP): A Bull Case Theory - Finviz
Swing Trade: What is JYNTs P E ratio telling usWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Wells Fargo Maintains Overweight Rating on INSP, Lowers Price Ta - GuruFocus
Will New CFO Hire And Inspire V Launch Plus 2026 Guidance Change Inspire Medical Systems' (INSP) Narrative? - Yahoo Finance
Insider Sell: John Rondoni Sells Shares of Inspire Medical Syste - GuruFocus
JPM26: Inspire Medical Systems projects a strong 2026 - Yahoo Finance
Inspire appoints Matt Osberg as CFO - MedTech Dive
Impulse Dynamics® Announces New Chief Financial Officer - The Manila Times
Inspire Medical Systems appoints Matt Osberg as new CFO By Investing.com - Investing.com Nigeria
Inspire Medical Systems (NYSE:INSP) Insider Sells $10,900.00 in Stock - MarketBeat
Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results - TipRanks
Jefferies raises Inspire Medical Systems stock price target to $100 on strong Q4 - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) sets CFO transition, preliminary 2025 results - Stock Titan
INSP: Inspire V drives growth with improved outcomes, strong guidance, and ongoing innovation - TradingView — Track All Markets
INSP: Inspire 5's launch accelerates growth, innovation, and patient outcomes, with strong 2026 outlook - TradingView — Track All Markets
Inspire Medical names new CFO, reports preliminary Q4 results - MassDevice
Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO - MSN
INSP Forecasts 10%-11% Growth by 2025 - GuruFocus
Inspire Medical Systems (INSP) Reports Strong Revenue Growth in 2025 - GuruFocus
INSP Appoints Matt Osberg as New Executive Vice President and CF - GuruFocus
Inspire Q4 Prel. Revenue Rises 12%, Sees Double-Digit Growth In 2026; Names Matt Osberg CFO - Nasdaq
Inspire Medical Systems appoints Matt Osberg as new CFO - Investing.com
Inspire Medical Systems Reports Preliminary Q4 2025 Results and Appoints New CFO - Quiver Quantitative
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance - The Manila Times
Allspring Global Investments Holdings LLC Has $298,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Do Inspire Medical Systems’ (INSP) Lawsuits Hint at Deeper Questions About Execution and Transparency? - Sahm
Inspire Medical slides after Medicare reimbursement policy change - MSN
Why We're Not Concerned Yet About Inspire Medical Systems, Inc.'s (NYSE:INSP) 32% Share Price Plunge - simplywall.st
Will Inspire Medical Systems Inc. stock benefit from commodity prices2025 Price Targets & Long-Term Growth Stock Strategies - ulpravda.ru
Is Inspire Medical Systems Inc. stock overvalued by current metrics2025 Short Interest & Free Long-Term Investment Growth Plans - ulpravda.ru
Can Inspire Medical Systems Inc. stock sustain institutional interestGap Down & Weekly High Return Stock Opportunities - ulpravda.ru
How Inspire Medical Systems Inc. stock reacts to bond yieldsJuly 2025 WrapUp & AI Powered Market Entry Strategies - ulpravda.ru
A Look At Inspire Medical Systems (INSP) Valuation After Lawsuits Over Inspire V Launch Disclosures - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) Stock Price Down 6.3%Here's Why - MarketBeat
Truist Securities Lowers Price Target for INSP to $120, Maintains 'Buy' Rating | INSP Stock News - GuruFocus
Truist Securities lowers Inspire Medical Systems stock price target to $120 - Investing.com Canada
Assessing Inspire Medical Systems (INSP) Valuation As Inspire V Lawsuits And Rollout Issues Weigh On Sentiment - Sahm
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - The Manila Times
2026 world cup world class players breakdown: Can Inspire Medical Systems Inc. stock sustain institutional interest2026 world cup usa national team third place match playmakers pressing system odds analysis breakdown - Улправда
Inspire Medical Systems (INSP) Hit by Execution Difficulties in Q3 - Finviz
January 5, 2026 Deadline Approaching: Join Class Action Against Inspire Medical Systems, Inc. (INSP)Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Recover Investment Losses: Class Action Initiated Against Inspire Medical Systems, Inc. (INSP) - ACCESS Newswire
Inspire Medical Systems, Inc. (NYSE: INSP) Investor Alert: Deadline in Lawsuit on January 5, 2026 - openPR.com
Lost Money on Inspire Medical Systems, Inc. (INSP)? Join Class Action Before January 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
2026-01-05 | Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Over Securities ViolationsContact Levi & Korsinsky Today | NYSE:INSP | Press Release - Stockhouse
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - The AI Journal
Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical - GlobeNewswire
INSPIRE MEDICAL FINAL DEADLINE ALERT: Bragar Eagel & - GlobeNewswire
The Gross Law Firm Reminds Inspire Medical Systems, Inc. Investo - GuruFocus
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):